ImmunityBio, Inc. - Common Stock (NQ:IBRX)
8.170
+0.760
(+10.26%)
Streaming Delayed Price
Updated: 12:19 PM EDT, Mar 25, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 18,768,379 |
| Open | 7.750 |
| Bid (Size) | 8.160 (1,300) |
| Ask (Size) | 8.170 (2,600) |
| Prev. Close | 7.410 |
| Today's Range | 7.450 - 8.220 |
| 52wk Range | 1.830 - 12.43 |
| Shares Outstanding | 391,156,513 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Most active stocks in Tuesday's session ↗
March 24, 2026
Why ImmunityBio Stock Is Down More Than 20% Today ↗
March 24, 2026
ImmunityBio Crashes On FDA Warning Over Anktiva Claims ↗
March 24, 2026
Why ImmunityBio Stock Is Up More Than 11% Today ↗
March 23, 2026
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now!
March 19, 2026
Why Did IBRX Stock Jump 7% In Pre-Market Today? ↗
March 17, 2026
Frequently Asked Questions
Is ImmunityBio, Inc. - Common Stock publicly traded?
Yes, ImmunityBio, Inc. - Common Stock is publicly traded.
What exchange does ImmunityBio, Inc. - Common Stock trade on?
ImmunityBio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ImmunityBio, Inc. - Common Stock?
The ticker symbol for ImmunityBio, Inc. - Common Stock is IBRX on the Nasdaq Stock Market
What is the current price of ImmunityBio, Inc. - Common Stock?
The current price of ImmunityBio, Inc. - Common Stock is 8.170
When was ImmunityBio, Inc. - Common Stock last traded?
The last trade of ImmunityBio, Inc. - Common Stock was at 03/25/26 12:19 PM ET
What is the market capitalization of ImmunityBio, Inc. - Common Stock?
The market capitalization of ImmunityBio, Inc. - Common Stock is 3.20B
How many shares of ImmunityBio, Inc. - Common Stock are outstanding?
ImmunityBio, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.